Copyright (c) 2013 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=bpaxLatest Financial News for BioSante Pharmaceuticals, Inc.en-USTue, 21 May 2013 17:04:13 GMThttp://l.yimg.com/a/i/brand/purplelogo/uh/us/fin.gifhttp://finance.yahoo.com/q/h?s=bpax14445http://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=bpaxyahoo_finance/2517888861Tue, 21 May 2013 17:04:13 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/biosante-pharmaceuticals-inc-reports-first-200500624.html[Business Wire] - BioSante Pharmaceuticals, Inc. today reported on its cash balance as of March 31, 2013 and financial results for the quarter ended March 31, 2013.yahoo_finance/1952793878Fri, 10 May 2013 20:05:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130510/bpax8-k.htmlyahoo_finance/2453321223Fri, 10 May 2013 13:11:48 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/biosante-pharmaceuticals-ani-pharmaceuticals-announce-200500031.html[Business Wire] - BioSante Pharmaceuticals, Inc. and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. announced today that each company will hold a special meeting of its stocyahoo_finance/3218068220Wed, 08 May 2013 20:05:00 GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13c5juhcb/*http://seekingalpha.com/article/1410771-huge-potential-but-tough-entry-for-female-sexual-dysfunction-drugs?source=yahooyahoo_finance/416142103Tue, 07 May 2013 20:25:15 GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12b3u5icr/*http://beta.fool.com/casey259/2013/05/01/4-bio-stocks-to-buy-today/32180/?source=eogyholnk0000001yahoo_finance/2268556616Wed, 01 May 2013 12:52:01 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ceregene-reports-data-parkinsons-disease-180000860.html[PR Newswire] - SAN DIEGO, April 19, 2013 /PRNewswire/ -- Ceregene, Inc. today announced the top-line data from its double-blind, randomized, controlled Phase 2b clinical study of CERE-120 (AAV-neurturin), a gene therapy ...yahoo_finance/3689839305Fri, 19 Apr 2013 18:00:00 GMThttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125m3irkb/*http://www.noodls.com/view/FE277D85543ED5B09CEE996FFAF3B1EE24FFAE82[at noodls] - LINCOLNSHIRE, Illinois and BAUDETTE, Minnesota (April 12, 2013) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. announced today that they have ...yahoo_finance/97024348Sat, 13 Apr 2013 14:30:36 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/biosante-pharmaceuticals-inc-ani-pharmaceuticals-220300655.html[Business Wire] - BioSante Pharmaceuticals, Inc. and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. announced today that they have entered into a new merger agreement pursuayahoo_finance/446152951Fri, 12 Apr 2013 22:03:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130412/bpax8-k.htmlyahoo_finance/500626550Fri, 12 Apr 2013 14:22:10 GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=13nnvj5ko/*http://seekingalpha.com/article/1328041-reviving-the-blockbuster-potential-of-libigel-for-biosante-and-antares-pharma?source=yahooyahoo_finance/1276891900Mon, 08 Apr 2013 19:53:08 GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=12juuefq7/*http://seekingalpha.com/article/1292491-antares-a-compelling-long-term-investment?source=yahooyahoo_finance/1033585839Thu, 21 Mar 2013 16:14:35 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/biosante-pharmaceuticals-inc-sends-letter-130000655.html[Business Wire] - BioSante Pharmaceuticals, Inc. today sent a letter to stockholders in connection with its proposed merger with ANI Pharmaceuticals, Inc. recommending that BioSante stockholders vote “FOR” the proposed merger.yahoo_finance/2626648009Tue, 19 Mar 2013 13:00:00 GMThttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125j9rhi1/*http://www.noodls.com/view/39F9B2DD8733B0AE00764DBB83CC9E0E581A1F9A[at noodls] - BioSante Announces Approval and Declaration of Contingent Value Rights Distribution ANI Announces Approval of Merger by Its Stockholders LINCOLNSHIRE, Illinois and BAUDETTE, Minnesota (March 15, 2013) ...yahoo_finance/3391631449Fri, 15 Mar 2013 21:01:02 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/130315/bpax8-k.htmlyahoo_finance/3629210846Fri, 15 Mar 2013 20:16:22 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/biosante-pharmaceuticals-announces-adjournment-stockholders-200500504.html[Business Wire] - BioSante Pharmaceuticals, Inc. and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc. announced today that ANI stockholders have approved the merger of ANI intyahoo_finance/3617982014Fri, 15 Mar 2013 20:05:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/ceregene-alzheimers-disease-cooperative-study-110000486.html[PR Newswire] - SAN DIEGO, March 13, 2013 /PRNewswire/ -- Ceregene, Inc. today announced the completion of enrollment in its double-blind Phase 2 clinical study of CERE-110 (AAV-NGF), a gene therapy product designed to ...yahoo_finance/4251941609Wed, 13 Mar 2013 11:00:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/biotech-industry-looks-benefit-fdas-122000385.html[Marketwired] - Programs developed by the U.S. Food and Drug Administration to speed up the approval process has been a major driver for growth within the Biotech Industry. In 2012, FDA drug approvals totaled a 15-year ...yahoo_finance/4134122779Tue, 12 Mar 2013 12:20:00 GMThttp://us.rd.yahoo.com/finance/external/noodlsaunz/rss/SIG=125671tgi/*http://www.noodls.com/view/D5DB74222E5041D3B55979E0436E7DDBF49216F0[at noodls] - Glass, Lewis & Co., LLC Recommends Vote "FOR" BioSante/ANI Merger LINCOLNSHIRE, Illinois (March 4, 2013) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced that Glass, Lewis & Co., ...yahoo_finance/4061652258Mon, 04 Mar 2013 20:24:50 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/news/glass-lewis-co-llc-recommends-140000569.html[Business Wire] - BioSante Pharmaceuticals, Inc. today announced that Glass, Lewis & Co., LLC, an independent proxy advisory firm, has recommended that BioSante stockholders vote “FOR” the adoption of the merger agreement between BioSante and ANIP Acquisition Company d/b/a ANI Pharmaceuticals, Inc.yahoo_finance/785791336Mon, 04 Mar 2013 14:00:00 GMT